1 2 3 4 5

Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine...

Marshall, Gary S.; Blatter, Mark; Marchant, Colin; More

Pediatric Infectious Disease Journal . 32(6):662-668, June 2013.

Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine...

Wheeler, Cosette M.; Harvey, Bryan M.; Pichichero, Michael E.; More

Pediatric Infectious Disease Journal . 30(12):e225-e234, December 2011.

IMMUNE RESPONSE AND ONE-YEAR ANTIBODY PERSISTENCE AFTER A FOURTH DOSE OF A NOVEL HAEMOPHILUS INFLUENZAE TYPE B AND NEISSERIA MENINGITIDIS SEROGROUPS C AND Y-TETANUS TOXOID...

Marshall, Gary S.; Marchant, Colin D.; Blatter, Mark; More

Pediatric Infectious Disease Journal . 29(5):469-471, May 2010.

Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants

Marchant, Colin D.; Miller, Jacqueline M.; Marshall, Gary S.; More

Pediatric Infectious Disease Journal . 29(1):48-52, January 2010.

PFAPA SYNDROME.

Marshall, Gary S.; Edwards, Kathryn M.; Lawton, Alexander R.

Pediatric Infectious Disease Journal . 8(9):658, September 1989.

1 2 3 4 5